New Insights in the Treatment of Severe Infections in the Multiple-Drug Resistant Situation (Highlights of the Daiichi Pharmaceutical Co., Ltd. Satellite Symposium to the 11th International Congress on Infectious Diseases)

21 June, 2018
Comparative Antimicrobial Susceptibility of Respiratory Tract Pathogens
photo_david David Felmingham, BSc MSc Dip LSHTM
Chief Executive , GR Micro Ltd, London, UK
Honorary Senior Lecturer
London School of Hygiene and Tropical Medicine
London, UK
Experience with Levofloxacin in a Critical Pathwey for the Treatment of Community-Acquired Pneumonia
photo_thomas Thomas J. Marrie, MD
Professor and Chair, Department of Medicine
University of Alberta, Edmonton, AB, Canada
Clinical Applications of Levofloxacin in Severe Infections
photo_wolfgang Wolfgang Graninger, MD PhD
Professor of Medicine
Head, Division of Infectious Diseases
and Chemotherapy
Internal Medicine
University of Vienna,
Vienna, Austria
New Insights in the Treatment by Levofloxacin
Thomas M. File, Jr, MD MS, Chair
Chief, Infectious Disease Service
Summa Health System, Akron, OH, USA
Professor of Internal Medicine
Northeastern Ohio Universities College of Medicine
Rootstown, OH, USA